Ravenmac Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 36.78%
- Profit Growth 87.44%
- Ebitda 40.45%
- Net Worth -66.06%
- Total Assets -5.39%
About Ravenmac Pharmaceuticals
Ravenmac Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 March 2010 and has a history of 14 years and 11 months. Its registered office is in Amritsar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan and Naresh Mahajan serve as directors at the Company.
Company Details
-
Location
Amritsar, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232PB2010PTC033648
-
Company No.
033648
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Mar 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Ravenmac Pharmaceuticals Private Limited offer?
Ravenmac Pharmaceuticals Private Limited offers a wide range of products and services, including Content Writing Service, Research Development Services, Common Disease Medicines, Anti Acne Drug, Popular Category, Bone & Joint Care.
Who are the key members and board of directors at Ravenmac Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Mahajan
|
Director | 28-Aug-2019 | Current |
|
Naresh Mahajan
|
Director | 03-Mar-2010 | Current |
Financial Performance of Ravenmac Pharmaceuticals.
Ravenmac Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.78% increase. The company also saw a substantial improvement in profitability, with a 87.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 66.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ravenmac Pharmaceuticals?
In 2020, Ravenmac Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ravenbhel Pharmaceuticals Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
-
Macmillon Pharmaceuticals Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
-
Ravenbhel Health Care Private LimitedSahil Mahajan is a mutual person
-
Salutemlab Formulations Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
-
Salutemlife Sciences Private Limited
Sahil Mahajan and Naresh Mahajan are mutual person
-
Polycoatt Films Private Limited
Sahil Mahajan and Naresh Mahajan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ravenmac Pharmaceuticals?
Ravenmac Pharmaceuticals has a workforce of 49 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravenmac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravenmac Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
